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Abstract
Objective: To examine whether quality of life (QOL), health status, and the relationships
between them varied by having a prostate cancer history. This study helps to inform the interface
between aging-related health decline and the survival state among older men with prostate cancer,
which is an important yet understudied public health issue.
Methods: Hierarchical linear models were used to analyze the cross-sectional data from the
nationally representative population-based Medical Expenditure Panel Survey. Using propensity
score matching, survivors (respondents with prostate cancer history) and controls (respondents
without a history of any cancer) (N=193 pairs) were matched based on seven socio-demographic
and health-related factors. QOL was measured using the mental and physical component scores of
the SF12. Health status included comorbidities, activities of daily living (ADL), instrumental
activities of daily living (IADL), and depressed mood.
Results: In bivariate analyses, survivors reported worse physical (42,72 vs 45.45 respectively,
p=.0040) and mental QOL (51.59 vs 53.73 respectively, p=0.0295) and more comorbidities (3.25
vs 2.78 respectively, p=0.0139) than controls. In multivariate analyses, for both survivors and
controls, better physical QOL was associated with fewer comorbidities (p<0.0001), no need help
with ADL (p=0.0011) and IADL (p=0.0162), and less depressed mood (p<0.0001); better mental
QOL was associated with no need help with IADL (p=.0005) and less depressed mood
(p<0.0001).
Conclusions: QOL of older men is affected by physical, functional, and psychological factors
rather than by prostate cancer history. Clinicians need to attend to aging-related health issues when
providing care for prostate cancer survivors to improve QOL.
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Cancer survivors are at an increased risk for age-related declines in health status physically,
psychologically, and functionally.1 Better physical and mental QOL has been associated
with less comorbidity among cancer survivors, especially those who survive five years and
longer.2 Some population-based studies have revealed that, compared to individuals without
cancer, cancer survivors have more decrements in self-rated health,3-5 psychological well-
being, and activities of daily living (ADL);4,6 more comorbidities;2 higher levels of lost
productivity;3-5 and similar quality of life (QOL).6
Although these population-based studies provided insights regarding physical, functional,
and psychological status and QOL during cancer survivorship, further examination is
warranted because of several methodological limitations. First, these studies included a
collection of survivors of multiple cancer sites, including both genders and with a wide age
range (from 18 to 65+ years of age).2-6 Members of such a heterogeneous population differ
significantly in their physical, emotional, social, and functional issues and QOL challenges,
which make it difficult to draw definitive conclusions regarding health status, QOL, and the
association between them. Second, these studies examined the differences in health status
between cancer survivors and non-cancer populations 4-6 or how QOL was affected by one
aspect of their health status (e.g., comorbidities).2 Little research has examined how QOL is
cumulatively affected by the overall health status of cancer survivors, especially aging
survivors who are challenged by functional impairment, various comorbidities, and
psychological problems.7,8 Third, these studies either did not examine QOL,3,4 one of the
most important patient-reported outcomes, or used a single-item measurement 6 or a set of
proxy measures 5 instead of a comprehensive assessment of QOL. Finally, although some
studies used non-cancer controls, 2-4 they used one or two matching variables (e.g., age), and
thus, the non-cancer population significantly differed from the cancer population in the
composition of age groups, marital status, education levels,2,4 health insurance coverage4,
and racial/ethnic background.2-4 It is unclear whether variations in study participants’
sociodemographic status have contributed to the observed differences in the health outcomes
between survivors and non-cancer controls.
To address the aforementioned limitations in population-based research, we investigated the
overall health status (i.e., including functional impairment, comorbidities, and psychological
problems), QOL, and the association between health status and QOL among prostate cancer
survivors (survivors) and matched controls without cancer (non-cancer controls).
Improvements in early detection and treatment have reduced prostate cancer-specific
mortality and increased the number of patients who survive for an extended period of time.
Yet men with prostate cancer often face physical and psychological morbidities while
managing the effects of prostate cancer and its treatment,9 which negatively affect the
multidimensional aspects of QOL including physical and mental QOL. 10,11
Furthermore, prostate cancer is most prevalent among older men; the number of prostate
cancer survivors will continue to rise as the population ages.12 The interface between
prostate cancer survivorship and the consequences of aging, including general health
decline, is becoming an increasingly important public health issue. Yet there is limited
evidence about whether prostate cancer survivors differ from the non-cancer general
population in health status, QOL, and the relationships between QOL and health status.
Using population-based national survey data and rigorous propensity score matching, we
examined (1) whether prostate cancer survivors who are 50 years and older had significantly
worse QOL and health status (functional status, comorbidities, and depressed mood) than
non-cancer matched controls; and (2) whether QOL was significantly related to health status
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variables in survivors and non-cancer controls. The results from this study provide empirical
evidence for comprehensive clinical care for prostate cancer survivors.
MATERIAL AND METHODS
Sample and propensity matching
The study sample, drawn from the 2009 Medical Expenditure Panel Survey (MEPS),13
included prostate cancer survivors and their matched controls without any cancer history.
MEPS is a nationally representative survey of health care utilization and expenditures in the
U.S. ambulatory population.13 This study focused on survivors who had a prostate cancer
diagnosis and who were 50 years of age or older at the time of the 2009 MEPS survey.
To reduce bias and increase estimation precision in this observational study,ENREF 1914 we
used rigorous propensity score matching to balance the large heterogeneities between the
survivor and control groups. A propensity score is a conditional probability that an
individual is in one condition rather than in another,14 e.g., having a history of prostate
cancer. In this study, we first identified, among the 36,855 MEPS respondents, 3,093 male
respondents who either had a history of prostate cancer (N=193) or no cancer at all; were 50
years or older; were of any of the following racial groups: non-Hispanic Whites, Hispanics,
or African/Black Americans; and had no missing values in the matching covariates and
variables of interest. We then conducted a Stata PSMATCH2; the full Mahalanobis
matching and the nearest neighbor matching strategies 14 were employed to match each of
the survivors with one male respondent without a history of any type of cancer based on
seven characteristic factors (see below). Finally, we obtained 193 matched pairs of survivors
and controls who had closest propensity scores, and thus, attained a random sample of the
non-cancer control candidates to match each prostate cancer survivor.
Matching covariates included seven factors that have been linked to QOL and health status
among prostate cancer survivors:15-17 race (i.e., non-Hispanic Whites, Hispanics, and
African Americans); age; education; marital status (married vs. not married); health
insurance (having any private, public only, or no insurance); family income; and Body Mass
Index (BMI).15-17 Regarding age, five-year intervals (50-54, 55-59, 60-64, 65-69, 70-74, or
≥75 years) were used. Educational attainment was categorized into two groups, i.e. ≤high
school or ≥some college. Family income was measured according to its relationship to the
poverty line as reported by U.S. Census Bureau in 2009 18 (adjusted by family size and
composition): low (<200% of the poverty line), middle (200%~400%), and high income
(>400%). Lifestyle is another factor that contributes to prostate cancer and other health
problems.15 BMI, used as a proxy of lifestyle and one of the matching factors, was collapsed
into 3 groups (<25, 25~30 and ≥30) because less than 1% of participants reported a BMI
≤18.5.
Measures
The outcome variable, QOL, was measured using the SF-12® Health Survey (version 2.0), a
validated shortened version of SF-36.19 MEPS provides the physical and mental component
scores which range from 0 to 100. With the population means at 50, higher scores indicate
better physical and mental QOL, respectively.19
The health status variables included functional impairments, the number of comorbid
conditions, and depressed mood. Higher values of these measures indicated having
functional impairment, more comorbidities, and worse depressed mood. Functional
impairments were measured using activities of daily living (ADL) and instrumental
activities of daily living (IADL). The ADL referred to whether the respondent needed help
or supervision with daily activities such as eating, bathing, and dressing. The IADL
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indicated the respondent’s needs for assistance with activities such as taking medications,
doing laundry, and going shopping. The need for help and supervision for ADL and IADL
was coded as 1 and no need for help as 0.
Comorbidities in MEPS were measured using a list of conditions that have relatively high
prevalence and for which generally accepted standards for appropriate clinical care have
been developed.13 The respondents were asked whether they had been diagnosed with major
diseases since age 18 such as diabetes, hypertension. The respondent’s having or not having
a diagnosis was coded as 1 or 0, respectively. The comorbidity index was the sum of values
of all comorbid conditions. Depressed mood was measured by Patient Health Questionnaire
(PHQ-2) 20 (having little interest or pleasure in doing things; feeling down, depressed, or
hopeless during the past two weeks).
Data Analysis
The matching covariates, QOL, and health status variables between survivors and non-
cancer controls were first compared to examine whether there was significant post-matching
difference between the two groups. SAS PROC GENMOD was used to account for
clustering effects due to pairing survivors and non-cancer controls. To achieve research aims
while accounting for the clustering effects, a series of hierarchical linear models were
specified using PROC MIXED (SAS 9.3, Cary, NC).21 Specifically, two crude models were
first constructed by separately regressing physical and mental QOL with respondents’ cancer
status (survivor=1 vs. control=0). A series of adjusted models were then specified by adding
to the crude models (1) the health status variables; (2) each interaction term between cancer
status and health status variables; and (3) all of the interaction terms simultaneously. Any
imbalanced covariates between survivor and control were included in model specification.
RESULTS
Descriptive analysis
Approximately 50% of the respondents were 65 years of age or older, non-Hispanic white,
married, insured with some types of private insurance, with high school or lower education,
with middle to high family income, and with a BMI at 25 or greater. After propensity score
matching, the survivors and non-cancer controls did not differ significantly in their race,
age, education, marital status, medical insurance status, and BMI (Table 1). Regarding
family income, there was no significant difference in the percentages of respondents in the
low income category between the two groups. Compared to non-cancer controls, however, a
higher percentage of survivors reported having middle incomes [59/193 (31%) vs. 50/193
(26%); p=.0478] and a lower percentage of survivors had high income [84/193 (43%) vs.
96/193 (50%); p=.0094]. Family income, thus, was included in model specification to
account for the between group imbalance.
Regarding QOL and health status variables (Table 2), the survivors had lower mean scores
of physical QOL (42.72 vs. 45.45; p=.0040) and mental QOL (51.59 vs. 53.73; p=.0295)
than the controls. This suggests that after balancing the matching covariates, the survivors
fared worse in physical and mental QOL than their non-cancer counterparts. The mean
number of comorbidities that the survivors reported was significantly higher than that
reported by the controls (3.25 vs. 2.78; p=.0139). No differences were seen in ADL, IADL
and depressed mood.
Model Specification
Physical QOL and Health Status—The PCS1 model in Table 3 shows that survivors
had lower scores in physical QOL than controls. The adjusted model PCS2 that included all
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health status variables indicates that poorer physical QOL was associated with needing help
with ADL (p=.0011) and IADL (p=.0162), and having more comorbidities and worse
depressed mood (both ps<.0001) in both groups. The PCS3-6 models separately examined
each of the interactions between cancer status and health status variables. All of the health
status variables remained significant (data not shown); neither cancer status nor the
interaction terms were significant. Thus, interaction terms were dropped off the model
specification; only the main effects of the cancer status, ADL, IADL, comorbidities, and
depressed mood remained in the final model (PCS2). Family income, controlled as a
covariate, was significant in all models (all ps<.05), suggesting that, compared to those who
reported low income, respondents in high income group had better physical QOL.
Mental QOL and Health Status—A similar model specification process was repeated
with the dependent variables being replaced by mental QOL (Table 3). In MCS1 model,
cancer status had a significant negative effect on mental QOL (p=.0349), suggesting that the
survivors had poorer mental QOL than controls without accounting for the effects of health
status. The MCS2 model examined the main effects of health status variables; better mental
QOL was associated with no need for help with IADL (p=.0005) and less depressed mood
(p<.0001) in both groups. The adjusted models MCS3-6 separately examined the effects of
the health status variables and the interaction terms between cancer status and each health
status variable. The main effects of IADL and depressed mood remained significant (both p
values<.001) (data not shown); the effects of cancer status and each of the interaction terms
were not significant. Thus, the interaction terms were dropped off and only the main effects
of health status variables remained in the final model (MCS2) in which IADL (p=.0005) and
depressed mood were significant (p<.0001). Family income was controlled for its imbalance
between groups; the effect of medium income was significant (p=.0012), suggesting that
participants who reported medium income had better mental QOL than those in low and
high income groups.
DISCUSSION
This population-based study examined the physical, psychological, and functional impacts
of the interplay of aging and prostate cancer and investigated the collective effects of a set of
health status variables on the mental and physical QOL among men 50 years of age and
older. We found survivors had lower physical and mental QOL and more comorbidities than
non-cancer controls but similar depressed mood. The percentage of individuals needing help
with ADL and IADL were similar between the two groups. These results corroborate the
evidence that older adult survivors are vulnerable to both cancer-related symptoms and
aging-related deterioration in health conditions.22
In addition, regardless of respondents’ prostate cancer history, better physical QOL was
associated with need no help with ADL and IADL, fewer comorbidities, and less depressed
mood; better mental QOL was associated with need no help with IADL function and less
depressed mood. Previous research has reported that prostate cancer-related physiological
and psychological symptoms significantly predicted QOL of men with localized prostate
cancer within the first 12 months of diagnosis.23 Given that 89% of the survivors in this
study were at least one year out since their cancer diagnosis our findings add to the literature
on the integral roles that aging-related physical, psychological, and functional factors play in
the QOL in intermediate- and long-term prostate cancer survivors.
The results of this study also suggested the importance of including multiple health status
variables in evaluating QOL of prostate cancer survivors. Findings across studies have been
inconsistent concerning the differences in mental and physical QOL between cancer
survivors and non-cancer populations.24,25 Focusing on how cancer status or type affected
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QOL, these studies have paid less attention to how QOL is affected by survivors’ health
status. In this study, when only respondents’ cancer status (i.e., having a history of prostate
cancer vs. no cancer) was taken into account, the results showed that survivors fared worse
in physical and mental QOL than non-cancer controls who had similar sociodemographic
background. However, the effect of cancer status on physical and mental QOL disappeared
when multiple health status variables were included in multivariate analyses. Similarly, the
relationships between QOL and health status did not vary by respondents’ cancer status.
These results suggest that, for older survivors, cancer occurs against a background of
functional declines and other chronic health conditions. Compared to the history of a
prostate cancer diagnosis, respondents’ health status variables were more important factors
when evaluating QOL for men 50 years and older.
Depressed mood was the only health status variable that negatively affected both physical
and mental QOL among these men. Consistent with previous findings,26 these results stress
the importance of evaluating depressive sequelae in cancer survivorship, because such
mental distress is likely treatable; early detection and intervention can improve depressed
mood,27 and ultimately, improve QOL for prostate cancer survivors. These findings
highlight the need to address psychological functioning as an integral aspect of cancer
survivorship care.
The number of comorbidities was negatively associated with physical QOL. Consistent with
the findings from earlier national surveys of elderly cancer patients,2,4 prostate cancer
survivors in MEPS reported significantly greater numbers of comorbidities than the non-
cancer controls. Fewer comorbid conditions have been associated with better physical and
mental QOL2 and improved estimated life expectancy and quality-adjusted life expectancy
in prostate cancer survivors.28 Thus, similar to caring for non-cancer populations, attention
to the management of comorbid conditions should be an integral element of survivorship
care to improve health outcomes for prostate cancer survivors.
Functional status (i.e., ADL and IADL) was significantly associated with different aspects of
men’s QOL. Consistent with the results of previous population-based studies of community-
dwelling people of 50 years and older,29 the results of this study indicated that needing no
help with ADL and IADL was associated with better physical QOL, and needing no help
with IADL was associated with better mental QOL. It is possible that men’s needing help
with ADL and IADL made their dependence on others more perceivable, which in turn
affected their sense of control and self-esteem, resulting in poorer physical and mental QOL.
Interestingly, similar percentages of survivors and controls reported needing assistance with
ADL and IADL in this study. In contrast, the results of an earlier study 4 using National
Health Interview Survey data reported significantly greater limitations in ADL or IADL in
cancer survivors than in respondents without cancer or without other illness. Further
research is needed to examine whether the differences in research methods between these
studies (i.e., use of rigorously matched non-cancer population and heterogonous survivors of
different age and gender and with different types of cancer) have contributed to the
differences in the findings.
The following limitations in this secondary analysis warrant acknowledgement. First, the
MEPS dataset started to have some cancer-related information in 2009. Yet important
variables such as cancer stage and treatment type were not available. Second, due to a lack
of cancer-related longitudinal data in MEPS, we used a cross-sectional design which has
limited causal conclusions of the relationships between QOL and health status. Finally,
depressed mood was measured using the two screening questions of the PHQ-2, which may
omit some of the symptomatology required for a clinical diagnosis via the Diagnostic and
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Statistical Manual of Mental Disorders system,30 and thus, may have limited sensitivity for
clinically significant cases of depression.
Nonetheless, this study of nationally representative population-based survey has used
propensity score matching to rigorously control for a series of potential confounders, thus
reducing biases and increasing the estimation precision. The results suggest that physical
and mental QOL of older men is affected by functional, physical, and psychological health
status but is not dominated by a history of prostate cancer. In order to improve QOL for
prostate cancer survivors, clinicians must be attentive not only to treating the cancer, but
also to addressing patients’ ADL and IADL needs, comorbidities, and depressed mood.
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Table 1








N % N %
Age
 50-54 6 3.11 6 3.11 1.00
 55-59 12 6.22 12 6.22 1.00
 60-64 31 16.06 28 14.51 .08
 65-69 35 18.13 37 19.17 .32
 70-74 34 17.62 34 17.62 1.00
 75+ 75 38.86 76 39.38 .78
Race/Ethnicity
 Non-Hispanic White 138 71.50 129 66.84 .09
 Hispanic 20 10.36 23 11.92 .36
 Black 35 18.13 41 21.24 .22
Marital Status
 Married 138 71.50 133 68.91 .32
 Not Married 55 28.50 60 31.09 .32
Education
 ≤High School 119 61.66 119 62.18 .81
 ≥Some College 74 38.34 74 37.82 .81
Family Income
 Low 47 24.35 50 25.91 .42
 Middle 50 25.91 59 30.57 <.05*
 High 96 49.74 84 43.52 .01
Medical Insurance
 Any Private 117 60.62 114 59.07 .49
 Public Only 73 37.82 76 39.38 .49
 Uninsured a 3 1.55 3 1.55
BMI
 <25 45 23.32 46 23.83 .8185
 25-30 93 48.19 94 48.70 .8474
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Table 2








N % N %
Health status
 ADL
  Need Help 10 5.18 14 7.25 .40
  No 183 94.82 179 92.75
 lADL
  Need Help 21 10. 88 28 14.51 .25
  No 172 89.12 165 85.49
Mean SD Mean SD p>|z|
 Comorbidities 2.78 2.06 3.25 2.05 .02
 Depressed Mood 0.26 0.60 0.39 0.74 .07
Quality of Life
 Physical QOL 45.45 11.42 42.72 11.33 <.01
 Mental QOL 53.73 9.20 51.59 10.48 .03
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